BNTX (BioNTech SE) Pangali Forward P/E
Institutional confidence in BioNTech SE (BNTX) oncology remains steady, as evidenced by the company's forward P/E NTM. Current price action via the 0.00 indicator demonstrates a price consolidation phase. While its status as a scientific pioneer in mRNA therapy strengthens the brand image, declining revenues from COVID-19 products and the risks of clinical failures are exerting significant pressure on the asset's quotes.
Rincian analitis perusahaan BioNTech SE
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- rincian utang lan likuiditas:
Rasio Total Utang marang Ekuitas BioNTech SE|BNTX - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas BioNTech SE|BNTX - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku BioNTech Inc.|BNTX - Utang jangka dawa|Utang jangka cendhak perusahaan BioNTech|Rasio cepet biontech.de
- indikator profitabilitas perusahaan lan kelipatan valuasi:
BNTX - Asil keuangan resik|Bathi sing dikarepake BioNTech SE|BNTX - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep BioNTech Group|BNTX - Rasio P/E diaturake wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan BioNTech Inc.|BNTX - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham (EPS TTM) BioNTech|BNTX - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan biontech.de|BNTX - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep BioNTech SE
Ringkesan analitik perusahaan:BioNTech
When constructing a long-term portfolio, the priority screening stage is the analysis of expected earnings. The forward P/E measures the current share price relative to the projected EPS, reflecting market expectations for future growth. The consistent recruitment of global oncologists and mRNA researchers confirms the scaling potential of BioNTech SE (BNTX). The value of 0.00 indicates the current equity premium. The price action regarding the company's valuation based on the forward P/E determines the sustainability of this trend.
Pesaing BioNTech SE (BNTX)
Prakiraan rega marang bathi ARGX (argenx)|ABVX (ABIVAX) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E ADMA (ADMA Bio)|Kapitalisasi marang proyeksi bathi Protagonist Corp (PTGX)|IMVT - Rega marang bathi mangsa ngarep|kiniksa.com (KNSA) - Prakiraan rega marang bathi|Grifols (GRFS) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Adaptive Biotech|Prakiraan rega marang bathi CLDX|Pangali Forward P/E Aurinia Corp|Rega marang bathi mangsa ngarep BioCryst (BCRX)|veratx.com - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Rasio prakiraan rega marang bathi|AbCellera Bio - Pangali Forward P/E|TRML: Rega marang bathi mangsa ngarep|PGEN: Pangali Forward P/E|PHAR - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Nektar Therapeutics Inc.|Rasio prakiraan rega marang bathi Upstream Bio, Inc. UPB|Rega marang bathi mangsa ngarep Zenas Biopharma, Inc. (ZBIO)|Immunome Bio - Rasio rega marang bathi mangsa ngarep|Gossamer Bio, Inc. - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep KALV (kalvista.com)|Septerna - Pangali Forward P/E|Rasio prakiraan rega marang bathi Pieris Pharma|SVRA: Pangali Forward P/E|Prakiraan rega marang bathi Rigel Corp|ANAB (AnaptysBio, Inc.) - Pangali Forward P/E|ATXS: Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi ENGN (enGene)|RAPT (RAPT Therapeutics Inc.) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Aerovate Therapeutics JBIO|Kapitalisasi marang proyeksi bathi Aclaris Therapeutics, Inc (ACRS)|Kyverna Therapeutics - Pangali Forward P/E|Rasio prakiraan rega marang bathi tizianalifesciences.com|CABA: Pangali Forward P/E|VTYX (Ventyx Biosciences Inc.) - Rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Theratechnologies Inc|Rasio rega marang bathi mangsa ngarep AVTX (Avalo Therapeutics Inc)|Prakiraan rega marang bathi ELDN (Eledon Pharmaceuticals)|Rasio kapitalisasi marang bathi mangsa ngarep AGEN|Climb Bio - Prakiraan rega marang bathi|ZURA: Rasio rega marang bathi mangsa ngarep|ATYR - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake ADAG|IMA: Pangali Forward P/E|Shattuck Labs - Pangali mangsa ngarep rega marang bathi|EQ (Equillium Inc) - Pangali Forward P/E|Pangali Forward P/E Connect Pharma|Rega marang bathi mangsa ngarep Immunic, Inc. (IMUX)|ATRA (atarabio.com) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep InflaRx IFRX|XFOR - Prakiraan rega marang bathi|Adicet - Pangali Forward P/E|CELU - Pangali Forward P/E|INMB (INmune Bio Corp) - Prakiraan rega marang bathi|Barinthus Biotherapeutics Corp - Pangali mangsa ngarep rega marang bathi|KZR (Kezar Life Sciences) - Pangali Forward P/E|sabbiotherapeutics.com (SABS) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Akari Therapeutics Plc (AKTX)|Prakiraan rega marang bathi enlivex.com ENLV|Rega marang bathi mangsa ngarep Q32 Bio QTTB|GOVX - Prakiraan rega marang bathi|EDSA: Prakiraan rega marang bathi|IBIO - Pangali Forward P/E|carismatx.com (CARM) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep XTLB|BOLT (Bolt Biotherapeutics Inc.) - Pangali Forward P/E|Rasio prakiraan rega marang bathi HCW Biologics Inc HCWB|Pangali Forward P/E APVO|Rega marang bathi mangsa ngarep AIM (AIM ImmunoTech, Inc.)|Pangali Forward P/E ADTX (Aditxt, Inc.)|Kapitalisasi marang proyeksi bathi GRI Bio Inc (GRI)|XRTX - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Vyome Therapeutics|Revelation Biosciences (REVB) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep INDP|Prakiraan rega marang bathi SCNI|CALI (CalciMedica Corp) - Rasio kapitalisasi marang bathi mangsa ngarep|Pangali Forward P/E AFMD|ALLK - Rasio prakiraan rega marang bathi|Pangali Forward P/E HOOK (HOOKIPA Pharma)|IGMS - Prakiraan rega marang bathi|iTeos Therapeutics, Inc. - Pangali Forward P/E|Pangali mangsa ngarep rega marang bathi OCEA (Ocean Biomedical Inc)|TCBP (TC BioPharm (Holdings) PLC) - Prakiraan rega marang bathi|Third Harmonic Bio Inc - Pangali mangsa ngarep rega marang bathi
